Glecirasib (Kras G12C Inhibitor) In Combination With Jab-3312 (Shp2 Inhibitor) In Patients With Kras P.G12C Mutated Solid Tumors.
Glecirasib;JAB-3312
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Glecirasib (Kras G12C Inhibitor) In Combination With Jab-3312 (Shp2 Inhibitor) In Patients With Kras P.G12C Mutated Solid Tumors. ### Output: Glecirasib;JAB-3312